五月 2026
prothena.com
显示 Similarweb 估计数据。
关联 GA4，公开验证您的网站指标
与您的成功同步
绑定 Google Analytics，验证您网站的流量及用户参与度指标
跳出率
38.72%
每次访问页数
1.89
平均访问时长
00:00:10
prothena.com的 10 大竞争对手
在 五月 2026 与 prothena.com 相似的前 10 名网站，按关键字流量、受众定位和市场重叠方面与 prothena.com 的关联性排名
The opioid crisis may not be front and center anymore, but it’s raging still. A major problem is that overdose-reversal drugs don’t last long enough to help users who opt out of hospital treatment after they are revived. Elysium Therapeutics Inc. CEO Greg Sturmer talks with Randy Osborne about his firm’s candidate for a solution to the medical and societal problem. The NIH – which has been helpful to Elysium since the company’s founding – the FDA, and others are working to advance a longer-lasting reversal agent. Experiments already done with approved reversers, as well as computer modeling that’s been used by regulators previously, will help in the push, Sturmer said. Download transcript
- 公司
- - -
- 行业
- - -
跳出率
46.05%
每次访问页数
1.55
平均访问时长
00:00:23
相似度评分
100%We knew that a pattern existed, but no one was seeing it. Occurring in about 32,000 people in the United States, systemic mastocytosis is a rare mast cell disorder.i Its constellation of disparate…
跳出率
45.72%
每次访问页数
1.75
平均访问时长
00:00:12
The Investor Relations website contains information about MacroGenics, Inc.'s business for stockholders, potential investors, and financial analysts.
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
27%
每次访问页数
1.99
平均访问时长
00:01:01
NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration.
跳出率
35.66%
每次访问页数
2.06
平均访问时长
00:00:50
prothena.com在 五月 2026 的前五名竞争对手是：bioworld.com、blueprintmedicines.com、ir.macrogenics.com、neuroderm.com等。
根据 Similarweb 的月访问量数据，prothena.com 在 五月 2026 的头号竞争对手是 bioworld.com。与 prothena.com 相似度排名第二的网站是 blueprintmedicines.com，排名第三的是 ir.macrogenics.com。
在 五月 2026，neuroderm.com 被评为与 prothena.com 相似度第四高的网站， 位居第五。
进入前十名榜单的其他五家竞争对手分别是 、、、 和 。